Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 102 entries
View as:

A Study of HS-20094 in Chinese Adults with Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06839664 Org: User:
Start: 11/11/24 End: 02/27/26 Due: 02/27/27

A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.

Phase: N/A Priority: Normal
NCT ID: NCT05367700 Org: User:
Start: 04/28/22 End: 09/30/26 Due: 09/30/27

Pharmacokinetic Study of HS-10365 Capsule in Subjects with Hepatic Impairment and Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT06823258 Org: User:
Start: 02/28/25 End: 07/31/25 Due: 07/31/26

Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT03902691 Org: User:
Start: 05/15/19 End: 05/30/22 Due: 05/30/23

Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR Mutations

Phase: N/A Priority: Normal
NCT ID: NCT04923906 Org: User:
Start: 08/11/21 End: 01/31/26 Due: 01/31/27

Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT02477969 Org: User:
Start: 02/27/14 End: 06/30/17 Due: 06/30/18

A Trial to Assess the Efficacy and Safety of Morinidazole in Patients With Appendicitis

Phase: N/A Priority: Normal
NCT ID: NCT03380793 Org: User:
Start: 09/30/16 End: 10/31/18 Due: 10/31/19

A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06110663 Org: User:
Start: 12/30/23 End: 02/28/25 Due: 02/28/26

Efficacy and Safety Study of PEX168 in Monotherapy Diabetes Mellitus Type 2 Patients

Phase: N/A Priority: Normal
NCT ID: NCT02477865 Org: User:
Start: 03/23/14 End: 02/28/17 Due: 02/28/18

PhaseⅠStudy of the HS-10241 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04477057 Org: User:
Start: 06/21/19 End: 12/31/21 Due: 12/31/22

First-in-Human Study to Investigate the Safety and Tolerability and Pharmacokinetics of HS-10383

Phase: N/A Priority: Normal
NCT ID: NCT05429723 Org: User:
Start: 03/01/22 End: 06/30/22 Due: 06/30/23

A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease

Phase: N/A Priority: Normal
NCT ID: NCT03391440 Org: User:
Start: 09/30/16 End: 12/31/18 Due: 12/31/19

Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02461914 Org: User:
Start: 08/01/15 End: 07/13/16 Due: 07/13/17

A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients

Phase: N/A Priority: Normal
NCT ID: NCT02511340 Org: User:
Start: 01/31/13 End: 12/31/15 Due: 12/31/16

A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.

Phase: N/A Priority: Normal
NCT ID: NCT05353205 Org: User:
Start: 11/23/21 End: 09/30/25 Due: 09/30/26

A Phase II Study of HS-10353 in Participants With Postpartum Depression

Phase: N/A Priority: Normal
NCT ID: NCT05937867 Org: User:
Start: 08/31/23 End: 10/31/25 Due: 10/31/26

Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT02467790 Org: User:
Start: 02/28/15 End: 05/31/16 Due: 05/31/17

Phase 1 Study in Healthy Participants and Participants With Kidney Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT06383897 Org: User:
Start: 05/31/24 End: 01/31/25 Due: 01/31/26

Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02472236 Org: User:
Start: 06/08/15 End: 01/18/16 Due: 01/18/17

A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation

Phase: N/A Priority: Normal
NCT ID: NCT04951648 Org: User:
Start: 07/15/21 End: 09/06/24 Due: 09/06/25

A Study of HS-10501 Tablets in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06359600 Org: User:
Start: 03/14/24 End: 06/30/25 Due: 06/30/26

A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05504213 Org: User:
Start: 01/12/22 End: 12/31/25 Due: 12/31/26

A Study of HS-10516 in Patients With VHL Syndrome Associated Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06553339 Org: User:
Start: 07/19/24 End: 07/31/28 Due: 07/31/29

A Study of HS-10383 in Chinese Adult Subjects With Refractory or Unexplained Chronic Cough (RUCC)

Phase: N/A Priority: Normal
NCT ID: NCT06246565 Org: User:
Start: 03/01/24 End: 06/01/26 Due: 06/01/27

Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04652297 Org: User:
Start: 12/31/20 End: 08/31/21 Due: 08/31/22